Will Valneva and Dynavax Score With Their Late-to-the-Party COVID Vaccine?
Valneva (NASDAQ: VALN) recently reported positive results from a late-stage study of COVID-19 vaccine VLA2001. The vaccine uses Dynavax's (NASDAQ: DVAX) Cpg 1018 adjuvant. In this Motley Fool Live video recorded on Oct. 20, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the potential for commercial success of this late-to-the-party vaccine.
Source Fool.com